CPZ and cancer: We developed CIDD-99 based on the CPZ pharmacophore, which showed that CIDD-99 produced cytotoxic effects in cancer cell lines and had an anti-tumor effect in Cal-27-derived xenografts (De La Chapa et al., 2019a; De La Chapa et al., 2019b).